Loading clinical trials...
Loading clinical trials...
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Other Pediatric Vaccines in Healthy Toddlers
Conditions
Interventions
MenACYW conjugate vaccine
MMR
+3 more
Locations
37
Mexico
Acapulco, Mexico
Mexico City, Mexico
Tlaltizapán, Mexico
Barnaul, Russia
Kazan', Russia
Krasnodar, Russia
Start Date
November 7, 2016
Primary Completion Date
July 19, 2018
Completion Date
July 19, 2018
Last Updated
April 5, 2022
NCT05252715
NCT03549325
NCT03493919
NCT00443846
NCT00161928
NCT00798304
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions